WHO vaccine-preventable diseases: monitoring system. 2015 global summary

Last updated 28-May-2015 (Data received as of 22-May-2015)
Next overall update July 2015
2014 data are provisional
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 1 Infant (under 12 months) mortality rate: 172
GDP / capita (US$): 1 Child (under 5 years) mortality rate: 182

Population data in thousands3

  2014  2013  2012  2011  2010  2000  1990  1980 
Total population 286  285  283  282  280  267  259  249 
Births
Surviving infants
Pop. less than 5 years 18  18  18  18  18  18  20  21 
Pop. less than 15 years 54  54  54  54  54  59  62  73 
Female 15-49 years 69  70  70  71  71  71  73  63 

Number of reported case

(Click for retrospective incidence data for Barbados)
Diphtheria
Japanese encephalitis
Measles 51  27 
Mumps
Pertussis
Polio*
Rubella
Rubella (CRS)
Tetanus (neonatal)
Tetanus (total)** 13 
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For desagregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Barbados)
Vaccine year result method % card seen                                                
BCG          57  92  95 
DTP1          93 
DTP3          91  91  87  91  86  93  91  60 
HepB_BD         
HepB3          91  91  87  91  86 
Hib3          91  91  87  91  86 
JapEnc         
MCV          92  87  90  93  85  94  87  41 
MCV2          90  89  90  94  96 
PCV1         
PCV3          91 
Pol3          91  91  88  91  90  86  90  99 
Rota1         
Rota_last         
Rubella1          92  87  90  93  85 
TT2plus          20 
PAB         
VAD1         
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: July 2015

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Barbados)
DTP1 93  93  93  93  93  97  82 
DTP3 87  87  91  86  93  91  60 
HepB3 87  87  91  86 
HepB_BD
Hib3 87  87  91  86 
MCV 90  90  93  85  94  87  41 
MCV2 90  90  94  96 
PCV3 75  75  75  75 
Pol3 88  88  91  90  86  90  99 
Rota_last

Number of districts in the country 10  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 60
From 80 to 89% 50
From 50 to 79% 0
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2014 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG 5 years; Yes
DT 5-7 years;
DTwP 18 months; 4.5 years; Yes
DTwPHibHepB 2, 4, 6 months; Yes
HPV 11 years (x2); Yes
HepB Yes adults
IPV 2, 4, 6, 18 months; 4.5, 10-11 years; Yes children of HIV mothers and from October 2015 to all children
Influenza_Adult >= 65 years; Yes health care workers and other risk groups
MMR 1, 3-5 years; Yes
OPV 2, 4, 6, 18 months; 4.5, 10-11 years; Yes
Pneumo_conj 2, 4, 6 months; Yes
Td 10-11 years; Yes
Varicella 1 year; Yes
YF Yes Travelers

Immunizaton indicators

Indicator Expected answer 2014  2013  2012  2011  2010  2009  2008 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR No  No  No  Yes  No  No  No 
What years does the MYP cover? number              
Nº of districts with microplans that include activities to raise immunization coverage number  

System performance

Total Nº districts in country number 10 
Nº districts with DTP3 coverage >=80% number 11 
% of districts with DTP3 coverage >=80% From 0 to 100% 110  100 
Nº districts with measles (MCV1) coverage >=95% number      
% of districts with MCV1 coverage >=95% From 0 to 100% 40       

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND No      Yes       
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes      Yes      Yes 

Finance

Immunization expenditure financed, using Government funds? From 0 to 100%       98  100  100  100 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR No  Yes  Yes  Yes  Yes     

Sources

 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.